ReviewThe Australasian journal of dermatology2020
Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.
Review in The Australasian journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.
- Adverse Events in Nonsurgical Facial Aesthetic Procedures: A Systematic Review and Meta-Analysis.Oral diseases · 2026Pooled it
- Long-Term Performance and Safety of a Superficial HA Filler With Tri-Hyal Technology on Different Facial Zones: Forehead, Cheeks, Crow's Feet, and Upper Lips.Journal of cosmetic dermatology · 2025Trial
- Hyaluronic Acid Filler VYC-25L for Jawline Restoration Yields High Satisfaction, Improved Jawline Measurements, and Sustained Effectiveness Across Skin Types, Age, and Gender for up to 12 Months.Aesthetic surgery journal · 2024Trial
- Comparative clinical study for the efficacy and safety of two different hyaluronic acid-based fillers with Tri-Hyal versus Vycross technology: A long-term prospective randomized clinical trial.Journal of cosmetic dermatology · 2023Trial
- Long-Term Efficacy and Tolerability of a Medium G' HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone.Clinical, cosmetic and investigational dermatology · 2023Trial
- Minimally Invasive Aesthetic Treatments for the Corrective Patient Archetype: Transforming Lives.Aesthetic plastic surgery · 2026Review
- Pilot Study: Hyaluronic Acid Fillers in the Management of Scars After Skin Cancer Surgery.Plastic and reconstructive surgery. Global open · 2026Article
- Management of Complications Following Botulinum Toxin Facial Injections: A Narrative Review.Cureus · 2026Review
- Preliminary Investigation and Safety Profile of a Novel Hybrid Filler (Hyaluronic Acid-Calcium Hydroxylapatite) in Asian Facial Rejuvenation.Plastic and reconstructive surgery. Global open · 2026Article
- Severe anaphylactic shock suspectedly induced by injection of recombinant humanized type III collagen lyophilized fiber for facial skin improvement: a case report.Frontiers in allergy · 2026Article
- Evaluation of Artificial Intelligence Chatbots for Facial Injection Planning: Comparative Performance and Safety Limitations.Aesthetic plastic surgery · 2025Observational
- Call for Mandatory Reporting of Serious Adverse Events in Aesthetic Medicine: "You Can't Manage What You Don't Measure".Plastic surgery (Oakville, Ont.) · 2025Article
- Advances in Poly-l-lactic Acid Injections for Facial and Neck Rejuvenation.Plastic and reconstructive surgery. Global open · 2025Article
- Article
- Extracorporeal Acoustic Shock Waves to Treat Complications of Polymethylmethacrylate.Aesthetic plastic surgery · 2025Article
- Hyaluronic Acid Filler Usage and Technique for the Facial Upper Third: A Comprehensive Review.Plastic and reconstructive surgery. Global open · 2025Article
- The Esthetic Use of Botulinum Toxins in Cancer Patients: Providing a Foundation for Future Indications.Toxins · 2025Review
- Long-term Efficacy and Safety of a Hyaluronic Acid-Based Dermal Filler With Tri-Hyal Technology to Enhance Lip Volume.Aesthetic surgery journal. Open forum · 2025Article
- Neuromodulator Co-Administration With a Vibration Device: Patient Comfort Study.Aesthetic surgery journal. Open forum · 2025Article
- Mild Allergic Reactions after Botulinum Toxin Injection: A Case Series and Literature Review.Plastic and reconstructive surgery. Global open · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes. As with any medical treatment, adverse events and complications may occur. Adverse events associated with these products are typically transient and mild to moderate in severity. Serious adverse events, such as infection and intravascular occlusion, are rare. Proper patient selection, consent and counselling, preparation and impeccable injection technique are important risk reduction strategies. Both clinicians and patients must be alert to the signs and symptoms of complications so that appropriate treatment can be started promptly. In this article, the authors review the current literature and provide their consensus recommendations for minimising adverse outcomes when treating patients with botulinum toxin or hyaluronic acid fillers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.